European Disease Progression Monitor: Edition 4

COVID-19 disease progression monitor

EU Disease-progression-review

Italy, Spain and France past COVID-19 peak

Germany and U.K. later peaks than EU

latest death rate in EU

EU5 past COVID-19 peak intensity

COVID-19 treatments and preventative therapies

disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition III

Related Insights

Video / Webinar

Healthcare

Investment Spotlight: Aesthetics, Dermatology and Med Spas

June 5, 2025

Life Sciences & Pharma

Building Resilience in a Commercial-Stage Pharma Company’s Supply Chain

April 16, 2025

Life Sciences & Pharma

Unlocking the Potential of Next-Generation PROTACs: A Strategic Roadmap for R&D Investment

March 7, 2025

Our client engaged L.E.K. Consulting to develop a market overview across multiple key therapeutic areas (e.g., oncology, immunology, neuroscience) and…

Published Articles

Life Sciences & Pharma

A Strategic Framework for Evaluating AI in Drug Discovery

December 6, 2024

Video / Webinar

Healthcare Services

AI in Healthcare: Passive, Reactive, or Proactive?

August 2, 2024

Video / Webinar

Healthcare Services

APAC's Booming Healthcare Data Monetization Market

July 18, 2024